Subarachnoid Hemorrhage: all 521 studies

Page 5 of 6. Open to participants first (126), then studies with results posted, then the rest; newest registration first within each.

• The Role of Biomarker in Serum, Cerebrospinal Fluid and Parenchyma in the Context of Aneurysmal Subarachnoid Hemorrhage.Status unknownNCT02142166Not applicable
• Safety Study of Carotid Body Neurostimulation to Treat Cerebral VasospasmStatus unknownNCT02129413Not applicable
• The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid HemorrhageCompletedNCT02129010
• An Innovative Non-invasive Acoustic Approach to Detect and Monitor Cerebral VasospasmWithdrawnNCT02093182
• Admission HbA1C in Aneurysmal Subarachnoid HemorrhageCompletedNCT02081820
• Neurological Outcome in Patients of Traumatic Subarachnoid HaemorrhageCompletedNCT02073890
• The Mortality and Changes in Quality of Life of Patients Suffering From SAH With Different Hydration StrategiesCompletedNCT02064075Phase 4
• Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular DiseaseStatus unknownNCT02062021
• CT Perfusion Imaging to Predict Vasospasm in Subarachnoid HemorrhageActive, not recruitingNCT02056769Not applicable
• Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured AneurysmsWithdrawnNCT02056574Phase 2
• SpareBrain - Mechanisms and Prevention of Secondary Brain Injury in Subarachnoid HaemorrhageCompletedNCT02026596
• Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)WithdrawnNCT02011321Phase 2
• Massage Technique for Pain, Anxiety and Delirium in SAH PatientsCompletedNCT01982656Not applicable
• Heart Rate and Initial Presentation of Cardiovascular Diseases (Caliber)Status unknownNCT01947361
• Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER StudyStatus unknownNCT01937065
• Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot StudyWithdrawnNCT01935908Phase 4
• Amnesia After Surgery for Anterior Communicating Aneurysm： High Resolution Magnetic Resonance (MR) Imaging FindingsCompletedNCT01919775
• Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid HemorrhageCompletedNCT01893190Phase 1/2
• Use of Lumbar Drain to Remove Clots in Patients Admitted to the Neuro-ICU After Subarachnoid Hemorrhage.Status unknownNCT01886521Not applicable
• Mechanical Ventilation in Brain-injured PatientsCompletedNCT01885507
• Effect of Intraventricular tPA Following Aneurysmal Subarachnoid HemorrhageWithdrawnNCT01878136Phase 1/2
• Safety and Efficacy Study of Etanercept for Aneurysmal Subarachnoid HemorrhageWithdrawnNCT01865630Phase 1
• Non-invasive Measuring of Cerebral Perfusion After Severe Brain Injury With Near-infrared-spectroscopy and ICGStatus unknownNCT01836848Not applicable
• Goal Directed Therapy After Aneurysmal Subarachnoid HaemorrhageCompletedNCT01832389Not applicable
• Risk Factors in the Initial Presentation of Specific Cardiovascular Disease SyndromesCompletedNCT01804439
• A New Multi-parameter Neuromonitoring System to Save Patients' Lives in Stroke and Brain InjuryCompletedNCT01802762Not applicable
• Cardiac Function in Severe Aneurysmal Subarachnoid Haemorrhage PatientsCompletedNCT01801800
• Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral AneurysmTerminatedNCT01801488
• A New Minimal-invasive Brain Tissue Probe Applying Near Infrared SpectroscopyCompletedNCT01801306Not applicable
• Hypercapnia to Prevent Secondary Ischemia in SAHCompletedNCT01799525Phase 1
• Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid HemorrhageCompletedNCT01799018
• MicroRNA Diagnostics in Subarachnoid HemorrhageCompletedNCT01791257
• Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid HemorrhageCompletedNCT01787123Phase 2/3
• Transcriptomic Signature of Vasospasm Consecutive to Sub-arachnoid Aneurismal HemorrhageCompletedNCT01779713
• Prognostic Value of Circulating Endothelial Progenitor Cells in Aneurysmal Subarachnoid HemorrhageStatus unknownNCT01773200
• Treatment of Subarachnoid Hemorrhage With Human AlbuminTerminatedNCT01747408Phase 1
• Endothelin-1 and Methabolites Concentrations in Mycrodialysis and Cerebrospinal Fluid in Subarachnoid Hemorrhage PatientsCompletedNCT01686763
• Cardiopulmonary Complication in Aneurysmal Subarachnoid Haemorrhage PatientsCompletedNCT01670838
• Dexmedetomidine and Subarachnoid HaemorrhageCompletedNCT01664520Phase 1/2
• Rehabilitation of Patients After Subarachnoid HemorrhageCompletedNCT01656317Not applicable
• Induced Hypertension for Treatment of Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid HaemorrhageTerminatedNCT01613235Phase 3
• Barrow Ruptured Aneurysm TrialStatus unknownNCT01593267Not applicable
• Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)TerminatedNCT01585311
• Lactate Therapy After Traumatic Brain InjuryCompletedNCT01573507Not applicable
• Risk Factors for Aneurysm RebleedingStatus unknownNCT01567449
• Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid HemorrhageTerminatedNCT01565590Phase 3
• Ultrasound Perfusion Imaging After Aneurysmal Subarachnoid HemorrhageStatus unknownNCT01537263
• Neuroinflammation and Bispectral Index After Subarachnoid HemorrhageStatus unknownNCT01516671
• HYdrogel Coil Versus Bare Platinum Coil in Recanalization Imaging Data StudyCompletedNCT01516658Not applicable
• Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid HaemorrhageCompletedNCT01447095Phase 2
• Cerebrospinal Fluid (CSF) Drainage StudyCompletedNCT01420978Not applicable
• Intensive Management of Pressure and Volume Expansion in Patients With Subarachnoid HemorrhageCompletedNCT01414894Phase 1
• The Tilburg Vasospasm StudyTerminatedNCT01407614Phase 2/3
• Monitoring of Delayed Ischemia After Subarachnoid HemorrhageCompletedNCT01406457
• Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid HemorrhageStatus unknownNCT01400360Not applicable
• Admission Bio-clinical Score to Predict One-year Outcomes in Coiled Subarachnoid Hemorrhage (SAH)CompletedNCT01357057
• The Role of Statins in Preventing Cerebral Vasospasm Secondary to Subarachnoid HemorrhageStatus unknownNCT01346748Phase 4
• Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage SubjectsTerminatedNCT01343537Early Phase 1
• Electrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain InjuryCompletedNCT01313975
• Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) PatientsStatus unknownNCT01292278
• Early Tracheostomy in Ventilated Stroke PatientsCompletedNCT01261091Not applicable
• EARLYdrain - Outcome After Early Lumbar CSF-drainage in Aneurysmal SAHCompletedNCT01258257Phase 3
• Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid HemorrhageWithdrawnNCT01232400Not applicable
• Acute Neurocardiogenic Injury After Subarachnoid Hemorrhage.CompletedNCT01218191
• A Study Comparing Modified Lund Concept and Cerebral Perfusion Pressure-targeted Therapy in Secondary Brain Ischaemia.CompletedNCT01206283Not applicable
• Bilateral Bispectral Index (BIS) StudyCompletedNCT01187420
• Ventriculostomy in Subarachnoid Hemorrhage (SAH): Intracranial Pressure (ICP) Open or Not?TerminatedNCT01169454
• Remote Ischemic Preconditioning in Subarachnoid HemorrhageCompletedNCT01158508Phase 1
• Impact of Cranioplasty On Cerebral PerfusionCompletedNCT01113645
• Endocrine Dysfunction and Quality of Life After Subarachnoid HemorrhageCompletedNCT01101711
• Intraventricular Tissue Plasminogen Activator (tPA) in the Management of Aneurysmal Subarachnoid HemorrhageStatus unknownNCT01098890Phase 2
• Sildenafil for Prevention of Cerebral VasospasmWithdrawnNCT01091870Phase 2
• High-dose Simvastatin for Aneurysmal Subarachnoid HaemorrhageCompletedNCT01077206Phase 2/3
• Epidemiology of Aeromedical EvacuationCompletedNCT01071382
• The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive TherapyWithdrawnNCT01042574Phase 4
• Cognitive Dysfunction After Aneurysmal Subarachnoid HaemorrhageCompletedNCT01038193
• Hypopituitarism After Aneurismal Subarachnoid HemorrhageCompletedNCT00962559
• Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid HemorrhageCompletedNCT00962546
• Serum ProcalcitoninCompletedNCT00954551
• Clazosentan in Aneurysmal Subarachnoid HemorrhageTerminatedNCT00940095Phase 3
• Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid HemorrhageTerminatedNCT00930072Phase 2
• Lycopene Following Aneurysmal Subarachnoid HaemorrhageStatus unknownNCT00905931Phase 2
• Outcomes Associated With Application of a Normothermia Protocol in Patients With Severe Neurological Insult and FeverCompletedNCT00890604Not applicable
• The Prediction of Intracranial Pressure and Clinical Outcome by Transcranial Doppler in Neurocritical PatientsStatus unknownNCT00886054
• Safety Study of Sildenafil in Treatment of Cerebral Aneurysm VasospasmWithdrawnNCT00871065Phase 2
• Lumbar Drainage in Subarachnoid HaemorrhageCompletedNCT00842049Phase 2
• Induced Hypertension for Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage:a Feasibility StudyTerminatedNCT00841633Phase 3
• Eicosapentaenoic Acid Cerebral Vasospasm Therapy StudyCompletedNCT00839449Phase 4
• Inhalatorial Sedation in Patient With Subarachnoid Hemorrhage (SAH) Versus Conventional Intravenous SedationCompletedNCT00830843Phase 4
• Clinical Efficacy of In-situ Thrombolysis in Case of Intraventricular Haemorraghia by Aneurysm RuptureCompletedNCT00823485Phase 2/3
• Cerebral Blood Flow (CBF) Disturbances Following Traumatic Brain Injury (TBI) and Subarachnoid Hemorrhage (SAH)CompletedNCT00807833
• Cortical Excitability in Patients With Severe Brain InjuryStatus unknownNCT00788723Not applicable
• Cervical Spinal Cord Stimulation for the Prevention of Cerebral VasospasmCompletedNCT00766844Phase 1
• The Factors Cause Vasospasm After Aneurysmal Subarachnoid HemorrhageStatus unknownNCT00745758
• Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical TrialCompletedNCT00731627Phase 3
• Time Frequency Analysis of Electrocardiogram and Blood Pressure in Intracranial Hemorrhage PatientsStatus unknownNCT00713375
• Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH)CompletedNCT00692744
• Hypothalamo-, Pituitary-, Adrenal Axis Dysfunction in Subarachnoid HemorrhageCompletedNCT00614887
• Evaluation of Cerebral Spinal Fluid and Blood in Patients With Subarachnoid HemorrhageActive, not recruitingNCT00593268
• Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAHTerminatedNCT00582868

← Subarachnoid Hemorrhage overview